Now Available for Public Comment: Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials
5 studies found for:    "Lichen sclerosis"
Hide Display Options

Display Options

Study Details
Participant Details
Identifiers
Dates
Rank Status Study
1 Terminated Progesterone vs Clobetasol Propionate in Vulvar Lichen Sclerosus
Condition: Vulvar Lichen Sclerosus
Interventions: Drug: Clobetasol propionate 0.05%;   Drug: Progesterone 8%
2 Completed Clobetasol Versus Pimecrolimus for Vulvar Lichen Sclerosus
Condition: Lichen Sclerosus
Interventions: Drug: pimecrolimus and clobetasol;   Drug: clobetasol 0.05% cream
3 Unknown  Tacrolimus Versus Clobetasol Propionate in the Treatment of Vulvar Lichen Sclerosus
Condition: Vulvar Lichen Sclerosus
Interventions: Drug: Tacrolimus cream;   Drug: Clobetasol cream
4 Completed Topical 0.05% Clobetasol Propionate in Vaseline Versus UVA-1 Phototherapy in Vulvar Lichen Sclerosus
Condition: Vulvar Lichen Sclerosus
Interventions: Other: UVA1 phototherapy;   Other: Cortisone
5 Recruiting Evaluation of the Role of Vibrational Spectroscopy in the Assessment of Vulval Disease
Conditions: Normal Vulval Skin;   Lichen Sclerosus;   High Grade Dysplasia - Usual Type ('VIN 2-3');   High Grade Dysplasia - Differentiated Type ('VIN 2-3');   Squamous Cell Carcinoma;   Epithelial Hyperplasia Without Atypia;   Atypia Not Otherwise Specified/ Low Grade Dysplasia ('VIN 1');   Pagets Disease of the Vulva
Intervention:

Indicates status has not been verified in more than two years